ArticleDrug design, development and therapy2025

Feasibility and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in Patients with Previously Immunotherapy-Treated Extensive-Stage Small Cell Lung Cancer: A Retrospective Exploratory Study.

Teng-Fei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.